Navigation Links
B. Melina Cimler, PhD, Former Senior Vice President of Regulatory & Quality at Adaptive Biotechnologies, Joins NDA Partners
Date:9/27/2018

NDA Partners Chairman Carl Peck, MD, announced today that Dr. B. Melina Cimler, a senior quality, regulatory, and in vitro diagnostic device expert with more than 28 years of experience in the life science and FDA-regulated global diagnostic industry has joined the firm as an Expert Consultant. Her experience includes leadership roles in regulatory strategy, quality systems, clinical affairs, research, and product development organizations with a focus on precision medicine.

Prior to joining NDA Partners, Dr. Cimler served as Senior Vice President of Regulatory and Quality at Adaptive Biotechnologies. She was formerly Head of Global Quality and Vice President of Quality, Regulatory, Clinical, and Government Affairs at Illumina Inc., where she defined and executed the regulatory strategy for the first next generation sequencing platform (MiSeqDx) to receive FDA marketing authorization.

Dr. Cimler has also previously held executive leadership positions in quality management, regulatory affairs, clinical development, and government affairs at Abbott Molecular, Beckman Coulter Inc., Gen-Probe Inc., and CR Bard, Inc., and she was formerly head of Product Development at Epitope, Inc. (now OraSure Technologies, Inc.).

According to Dr. David Feigal, NDA Partners’ Medical Device Practice Manager, “Dr. Cimler’s expertise in regulatory strategies, quality management, clinical affairs, and product development, focus on precision medicine, and experience in the global in vitro diagnostic industry makes her a welcome addition to our team of Expert Consultants. We are very pleased that she has joined NDA Partners.”

Dr. Cimler earned her doctoral degree in pharmacology and her bachelor’s degrees in biology and chemistry from the University of Washington. She currently serves on the Board of Directors of Nanostics, Inc. and is a Scientific Board member of M3 Biotechnology.

About NDA Partners
NDA Partners is a life sciences management consulting firm focused on providing product development and regulatory services to the pharmaceutical, biotechnology, and medical device industries worldwide. The highly experienced Principals and Premier Experts of NDA Partners include three former FDA Center Directors; the former Chairman of the Medicines and Healthcare Products Regulatory Agency (MHRA) in the UK; an international team of more than 100 former pharmaceutical industry and regulatory agency senior executives; and an extensive roster of highly proficient experts in specialized areas including nonclinical development, toxicology, pharmacokinetics, CMC, medical device design control and quality systems, clinical development, regulatory submissions, and development program management. Services include product development and regulatory strategy, expert consulting, high-impact project teams, and management of client product development programs.

Contact
Earle Martin, Chief Executive Officer
Office: 540-738-2550
MartinEarle(at)ndapartners.com

Read the full story at https://www.prweb.com/releases/b_melina_cimler_phd_former_senior_vice_president_of_regulatory_quality_at_adaptive_biotechnologies_joins_nda_partners/prweb15750970.htm.


'/>"/>
Source: PRWeb
Copyright©2018 Vocus, Inc.
All rights reserved


Related biology technology :

1. Stemina Biomarker Discovery Prepares to Commercialize Autism Diagnostic Products; Appoints New Board Member, Heiner Dreismann, Former Head of Roche Molecular Diagnostics
2. John W. Sheets Jr., Former FDA Director Of The Office Of Device Evaluation, Joins NDA Partners As Expert Consultant
3. Former VP of Clinical Pharmacology at Nektar Therapeutics, Michael A. Eldon, PhD, FCP, Joins NDA Partners as Expert Consultant
4. Former Associate Director of Product Development R&D at Allergan, Melissa Kirkegaard, joins NDA Partners as Expert Consultant
5. Former Vice President of Development Operations at XenoPort, Sami Karaborni, PhD, joins NDA Partners as Expert Consultant
6. Former CEO of Eurofins Advantar Laboratories, Richard Kenley, PhD, joins NDA Partners as Expert Consultant
7. Former FDA Official to Conduct Popular ComplianceOnline Seminar on FDA's GMP Expectations for Phase I and First-in-Man Clinical Trials
8. Former P&G VP Appointed New Industry Expert at Verixs Advisory Board
9. Former Director of FDA Division of Biostatistics, Gregory Campbell, PhD, joins NDA Partners as Expert Consultant
10. Vinod Shah, PhD, Former Senior Research Scientist in FDA Office of Pharmaceutical Sciences, Joins NDA Partners as Expert Consultant
11. Former Allergan Chief David Pyott Signs on as Special Advisor to Sienna Biopharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2018)... ... 08, 2018 , ... uBiome, the leader in microbial genomics, ... President of Andes Biotechnologies, to its Scientific Advisory Board. Joining the board of ... expertise on the genetic studies of hepatitis viruses. The appointment will help uBiome ...
(Date:11/7/2018)... ... November 07, 2018 , ... Since September of ... increase awareness of the adult tissue stem cell counting problem in stem cell ... company is intensifying this effort with new educational publications and presentations at clinical ...
(Date:11/5/2018)... ... November 05, 2018 , ... Frederick National Laboratory for Cancer ... to science research and education in the Frederick County area. , Frederick ... access to STEM-based undergraduate and graduate degree and certificate programs offered by partnering ...
(Date:11/5/2018)... ... November 05, 2018 , ... ... 2Blades’ Transcription Activator Like (TAL) effector code technology for applications in advancing research ... the technology in plants. Since its discovery in 2009, the efficacy of TAL effector-based ...
Breaking Biology Technology:
(Date:12/5/2018)... ... 2018 , ... Slone Partners, North America’s leading executive search ... at Karius, Inc. as Chief Commercial Officer. Now responsible for developing, executing, and ... in Redwood City, California and report to CEO Mickey Kertesz Ph.D. , ...
(Date:11/29/2018)... , ... November 29, 2018 , ... ... excited to collaborate with the new NSF Engineering Research Center for Cell ... collaborators brought together to develop transformative tools and technologies for the consistent, scalable ...
(Date:11/27/2018)... , ... November 27, 2018 , ... ... cryogenics industry a sealing solution with a broader range of usage temperature compared ... PEEK expert will introduce its new VICTREX CT™ 200 for dynamic sealing applications ...
Breaking Biology News(10 mins):